69 related articles for article (PubMed ID: 2531188)
1. Adenovirus E1A products activate the Ig k-chain enhancer in fibroblasts. A possible involvement of the NF-kB binding site.
Shurman L; Sen R; Bergman Y
J Immunol; 1989 Dec; 143(11):3806-12. PubMed ID: 2531188
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Ig kappa-chain enhancer by the adenovirus E1A gene products. Repression in lymphoid cells, activation in fibroblasts.
Bergman Y; Shavit D
J Immunol; 1988 Mar; 140(6):2073-80. PubMed ID: 2964488
[TBL] [Abstract][Full Text] [Related]
3. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
Brockmann D; Schäfer D; Kirch HC; Esche H
Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
[TBL] [Abstract][Full Text] [Related]
4. Organization of the transcription factor binding sites in the kappa Ig intron enhancer. Effects of position, orientation, and spacing.
Schanke JT; Van Ness BG
J Immunol; 1994 Nov; 153(10):4565-72. PubMed ID: 7963528
[TBL] [Abstract][Full Text] [Related]
5. Differential nuclear expression of enhancer A DNA-binding proteins in human first trimester trophoblast cells.
Boucraut J; Hawley S; Robertson K; Bernard D; Loke YW; Le Bouteiller P
J Immunol; 1993 May; 150(9):3882-94. PubMed ID: 8473737
[TBL] [Abstract][Full Text] [Related]
6. The first exon of Ad12 E1A excluding the transactivation domain mediates differential binding of COUP-TF and NF-kappa B to the MHC class I enhancer in transformed cells.
Kushner DB; Pereira DS; Liu X; Graham FL; Ricciardi RP
Oncogene; 1996 Jan; 12(1):143-51. PubMed ID: 8552385
[TBL] [Abstract][Full Text] [Related]
7. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
[TBL] [Abstract][Full Text] [Related]
8. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
[TBL] [Abstract][Full Text] [Related]
10. E1a revisited: the case for multiple cooperative trans-activation domains.
Braithwaite AW; Nelson CC; Bellett AJ
New Biol; 1991 Jan; 3(1):18-26. PubMed ID: 1828178
[TBL] [Abstract][Full Text] [Related]
11. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box.
Suzuki T; Hirai H; Fujisawa J; Fujita T; Yoshida M
Oncogene; 1993 Sep; 8(9):2391-7. PubMed ID: 8361755
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of host and viral genes by the adenovirus E1B 19K tumor antigen.
Herrmann CH; Dery CV; Mathews MB
Oncogene; 1987; 2(1):25-35. PubMed ID: 2963990
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Ig germ-line gamma 1 promoter. Involvement of C/enhancer-binding protein transcription factors and their possible interaction with an NF-IL-4 site.
Lundgren M; Larsson C; Femino A; Xu M; Stavnezer J; Severinson E
J Immunol; 1994 Oct; 153(7):2983-95. PubMed ID: 8089482
[TBL] [Abstract][Full Text] [Related]
14. A TATA box implicated in E1A transcriptional activation of a simple adenovirus 2 promoter.
Wu L; Rosser DS; Schmidt MC; Berk A
Nature; 1987 Apr 2-8; 326(6112):512-5. PubMed ID: 2951598
[TBL] [Abstract][Full Text] [Related]
15. The intronic immunoglobulin kappa gene enhancer acts independently on rearrangement and on transcription.
Kallenbach S; Babinet C; Pournin S; Cavelier P; Goodhardt M; Rougeon F
Eur J Immunol; 1993 Aug; 23(8):1917-21. PubMed ID: 8344354
[TBL] [Abstract][Full Text] [Related]
16. Repression of enhancer activity by the adenovirus E1A tumor protein(s) is mediated through a novel HeLa cell nuclear factor.
Reifel-Miller AE; Berg DT; Grinnell BW
J Biol Chem; 1991 Jul; 266(21):13873-82. PubMed ID: 1830310
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters.
Webster KA; Muscat GE; Kedes L
Nature; 1988 Apr; 332(6164):553-7. PubMed ID: 2965790
[TBL] [Abstract][Full Text] [Related]
18. Transcription activation by the adenovirus E1a protein.
Lillie JW; Green MR
Nature; 1989 Mar; 338(6210):39-44. PubMed ID: 2521923
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-kB with other transcription factor families.
Himes SR; Coles LS; Katsikeros R; Lang RK; Shannon MF
Oncogene; 1993 Dec; 8(12):3189-97. PubMed ID: 7504230
[TBL] [Abstract][Full Text] [Related]
20. The immunoglobulin heavy chain enhancer is stimulated by the adenovirus type 2 E1A products in mouse fibroblasts.
Borrelli E; Hen R; Wasylyk C; Wasylyk B; Chambon P
Proc Natl Acad Sci U S A; 1986 May; 83(9):2846-9. PubMed ID: 2939459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
